Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040

Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 mill...

Full description

Saved in:
Bibliographic Details
Published inThoracic cancer Vol. 14; no. 1; pp. 3 - 11
Main Authors Liu, Chun‐Quan, Ma, Yun‐Lei, Qin, Qi, Wang, Pei‐Hao, Luo, Yi, Xu, Peng‐Fei, Cui, Yong
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.01.2023
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040.
AbstractList Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Abstract Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph abstract showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040.
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning. Esophageal cancer is one of the most malignant cancers, with more than 0.6 million new cases of esophageal cancer and 0.54 million deaths worldwide in 2020. In current review, we present the global epidemiology of esophageal cancer in 2020 and projections to two decades later at different levels of continents, regions and countries and analyze them in gender, race, geographic region, and human development index. Graph showed global and top 3 countries with the highest incident cases of esophageal cancer in 2020 and projections to 2030 and 2040.
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from esophageal cancer have risen rapidly in recent decades. It is one of the most malignant cancers, with more than 0.6 million new cases and 0.54 million deaths worldwide in 2020. Here, we present the global epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040 at different geographical levels of continents, regions and countries, and analyze them by gender, race, geographic region and human development index. We summarize the prospects for the esophageal cancer burden and risk factors in different areas, which will be useful for global esophageal cancer clinical therapy and cancer control planning.
Author Ma, Yun‐Lei
Xu, Peng‐Fei
Cui, Yong
Qin, Qi
Liu, Chun‐Quan
Wang, Pei‐Hao
Luo, Yi
AuthorAffiliation 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences University of Pittsburgh Pittsburgh Pennsylvania USA
2 School of Pharmaceutical Sciences Wuhan University Wuhan China
1 Department of Thoracic Surgery Beijing Friendship Hospital, Capital Medical University Beijing China
AuthorAffiliation_xml – name: 2 School of Pharmaceutical Sciences Wuhan University Wuhan China
– name: 3 Center for Pharmacogenetics and Department of Pharmaceutical Sciences University of Pittsburgh Pittsburgh Pennsylvania USA
– name: 1 Department of Thoracic Surgery Beijing Friendship Hospital, Capital Medical University Beijing China
Author_xml – sequence: 1
  givenname: Chun‐Quan
  orcidid: 0000-0002-7075-3732
  surname: Liu
  fullname: Liu, Chun‐Quan
  organization: Beijing Friendship Hospital, Capital Medical University
– sequence: 2
  givenname: Yun‐Lei
  surname: Ma
  fullname: Ma, Yun‐Lei
  organization: Beijing Friendship Hospital, Capital Medical University
– sequence: 3
  givenname: Qi
  surname: Qin
  fullname: Qin, Qi
  organization: Beijing Friendship Hospital, Capital Medical University
– sequence: 4
  givenname: Pei‐Hao
  surname: Wang
  fullname: Wang, Pei‐Hao
  organization: Beijing Friendship Hospital, Capital Medical University
– sequence: 5
  givenname: Yi
  surname: Luo
  fullname: Luo, Yi
  organization: Beijing Friendship Hospital, Capital Medical University
– sequence: 6
  givenname: Peng‐Fei
  orcidid: 0000-0001-6854-6040
  surname: Xu
  fullname: Xu, Peng‐Fei
  email: pex9@pitt.edu, dyxufei@sina.com, dyxufei@sina.com
  organization: University of Pittsburgh
– sequence: 7
  givenname: Yong
  surname: Cui
  fullname: Cui, Yong
  email: cywork1@sina.com
  organization: Beijing Friendship Hospital, Capital Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36482832$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1vEzEQtVARLaFnbmglLlzS-tvrC1IVFSiqxKWcrVmvnTra2Iu9AeXf421KRHupDx5r_N7zeN68RScxRYfQe4IvSF2XRAm9VIrwC8IVF6_Q2TFzcjxjeYrOS9ngulirMRVv0CmTvKUto2fo-_UYercNaUjrfZN840oa72HtYGgsROtyE2JDMcUNxL4Zc9o4O4UUSzOlmmeHPMUcv0OvPQzFnT_GBfr55fpu9W15--PrzerqdmmF1mJJW0EVASJ6TWhLnAfuNfM9w1IBsQpk13pFpGPaa0tZx4V1NVjaSyUcYQt0c9DtE2zMmMMW8t4kCOYhkfLaQJ6CHZwBrKzi4DUQzSXvOt5iKz1mkjEq6r5Anw9a467but66OGUYnog-vYnh3qzTb6NbXFuOq8CnR4Gcfu1cmcw2FOuGAaJLu2KoEowRzOhc98dn0E3a5VhbVVGy2qMJmwU__F_RsZR_llXA5QFgcyolO3-EEGzmuTCz82aeAvMwF5UhnjFsmGA2sX4pDC_z_oTB7V96xtytrg68v-0ExTA
CitedBy_id crossref_primary_10_11569_wcjd_v32_i2_102
crossref_primary_10_1007_s00384_025_04849_2
crossref_primary_10_1016_j_jfma_2024_05_014
crossref_primary_10_1016_j_gassur_2025_101977
crossref_primary_10_1158_1055_9965_EPI_23_1343
crossref_primary_10_3390_diagnostics14131396
crossref_primary_10_1007_s12029_024_01159_8
crossref_primary_10_20517_2574_1225_2024_07
crossref_primary_10_1016_j_intimp_2024_112362
crossref_primary_10_1038_s41416_024_02683_x
crossref_primary_10_1093_jrr_rrae041
crossref_primary_10_1007_s11864_025_01308_6
crossref_primary_10_1002_cam4_70212
crossref_primary_10_3390_medicina60111901
crossref_primary_10_1186_s43042_024_00564_9
crossref_primary_10_5604_01_3001_0054_9779
crossref_primary_10_4236_jbm_2025_133007
crossref_primary_10_1007_s12291_024_01219_7
crossref_primary_10_1186_s12893_024_02562_5
crossref_primary_10_3389_fonc_2023_1344328
crossref_primary_10_1016_j_lana_2024_100954
crossref_primary_10_1016_j_clon_2024_03_020
crossref_primary_10_1016_j_radcr_2024_10_072
crossref_primary_10_3389_fmed_2024_1356752
crossref_primary_10_1007_s10620_024_08375_z
crossref_primary_10_3748_wjg_v30_i38_4168
crossref_primary_10_1016_j_gassur_2023_11_016
crossref_primary_10_1007_s11010_023_04913_x
crossref_primary_10_1177_26345161231198626
crossref_primary_10_1002_cam4_6078
crossref_primary_10_21518_ms2024_527
crossref_primary_10_3748_wjg_v30_i11_1621
crossref_primary_10_7759_cureus_47835
crossref_primary_10_3390_jcm12227086
crossref_primary_10_1186_s12967_024_05825_0
crossref_primary_10_3892_or_2024_8860
crossref_primary_10_1016_j_cbi_2024_110875
crossref_primary_10_7326_M24_0377
crossref_primary_10_7759_cureus_79274
crossref_primary_10_4103_jmu_jmu_26_23
crossref_primary_10_1097_01_JAA_0001007328_84376_da
crossref_primary_10_1016_j_ijscr_2024_110708
crossref_primary_10_1097_MS9_0000000000002674
crossref_primary_10_1172_JCI173649
crossref_primary_10_1111_jcmm_18294
crossref_primary_10_3390_cells14060411
crossref_primary_10_1093_dote_doae058
crossref_primary_10_1136_spcare_2024_005073
crossref_primary_10_3390_molecules29010230
crossref_primary_10_1016_j_soi_2024_100104
crossref_primary_10_1177_10732748241302957
crossref_primary_10_3390_bioengineering12010090
crossref_primary_10_14309_crj_0000000000001435
crossref_primary_10_5090_jcs_24_078
crossref_primary_10_1097_MD_0000000000040899
crossref_primary_10_2147_PPA_S472858
crossref_primary_10_1097_MD_0000000000038064
crossref_primary_10_12677_ACM_2023_13122646
crossref_primary_10_3390_cancers16020240
crossref_primary_10_36290_vnl_2023_108
crossref_primary_10_1016_j_humgen_2024_201312
crossref_primary_10_1016_j_biopha_2024_117368
crossref_primary_10_1016_j_prp_2024_155223
crossref_primary_10_3748_wjg_v30_i20_2638
crossref_primary_10_1007_s00464_024_10824_9
crossref_primary_10_3390_jcm14061845
crossref_primary_10_1016_j_mrgentox_2024_503766
crossref_primary_10_24884_0042_4625_2024_183_1_42_46
crossref_primary_10_3389_fgene_2024_1249751
crossref_primary_10_1097_COC_0000000000001147
crossref_primary_10_1016_j_ijbiomac_2024_133814
crossref_primary_10_1016_j_biopha_2024_117693
crossref_primary_10_3892_ijmm_2025_5503
crossref_primary_10_1016_j_heliyon_2023_e22654
crossref_primary_10_1007_s10388_024_01044_0
crossref_primary_10_1016_j_gassur_2024_07_004
crossref_primary_10_3390_cancers16081468
crossref_primary_10_3390_cancers16132460
crossref_primary_10_3904_kjim_2025_029
crossref_primary_10_3389_fonc_2023_1144516
crossref_primary_10_1016_j_ejphar_2025_177309
crossref_primary_10_1016_j_mtbio_2024_101394
crossref_primary_10_3390_cancers16234007
crossref_primary_10_3390_ijms25052691
crossref_primary_10_2147_DDDT_S476457
crossref_primary_10_1111_jgh_16689
crossref_primary_10_1371_journal_pone_0319854
crossref_primary_10_1016_j_athoracsur_2024_05_044
crossref_primary_10_3892_ijo_2025_5738
crossref_primary_10_1259_bjr_20220685
crossref_primary_10_1038_s41388_024_03123_z
crossref_primary_10_1016_j_jss_2024_04_067
crossref_primary_10_1016_j_saa_2024_124461
crossref_primary_10_1016_j_asjsur_2024_04_149
crossref_primary_10_1002_hsr2_1342
crossref_primary_10_1016_j_ctro_2024_100817
crossref_primary_10_1093_dote_doae063
crossref_primary_10_1186_s12885_024_13151_3
crossref_primary_10_3389_fimmu_2023_1206504
crossref_primary_10_1186_s12911_023_02235_y
crossref_primary_10_3390_cancers17071085
crossref_primary_10_4103_jfmpc_jfmpc_1150_24
crossref_primary_10_1053_j_gastro_2024_07_001
crossref_primary_10_1111_1759_7714_15246
crossref_primary_10_1002_ags3_12847
crossref_primary_10_1007_s00540_024_03432_3
crossref_primary_10_3390_cancers16030658
crossref_primary_10_4240_wjgs_v16_i5_1255
crossref_primary_10_1136_gutjnl_2024_333227
crossref_primary_10_1186_s12964_024_01475_3
crossref_primary_10_1007_s00210_025_03902_9
crossref_primary_10_1200_GO_24_00209
crossref_primary_10_58931_cot_2024_1220
crossref_primary_10_1515_iss_2023_0021
crossref_primary_10_1186_s40364_024_00718_2
crossref_primary_10_3904_kjim_2024_201
crossref_primary_10_1139_bcb_2023_0067
crossref_primary_10_1016_j_jtho_2023_12_021
crossref_primary_10_1016_j_ncrna_2023_05_009
crossref_primary_10_1016_j_jcmgh_2024_01_008
crossref_primary_10_3892_ol_2024_14406
crossref_primary_10_1016_j_humgen_2024_201355
crossref_primary_10_1097_MD_0000000000033895
crossref_primary_10_1007_s00261_024_04281_0
crossref_primary_10_4103_ATMR_ATMR_166_24
crossref_primary_10_1007_s10388_025_01112_z
crossref_primary_10_1093_pubmed_fdae311
crossref_primary_10_1080_00365521_2024_2396479
crossref_primary_10_1002_ijc_34881
crossref_primary_10_1016_j_ijheh_2024_114466
crossref_primary_10_1016_j_canep_2023_102486
crossref_primary_10_1093_dote_doae086
crossref_primary_10_3389_fimmu_2024_1509051
crossref_primary_10_1007_s00761_024_01661_5
crossref_primary_10_1007_s00210_025_03861_1
crossref_primary_10_1016_j_wneu_2024_04_130
crossref_primary_10_1093_bjsopen_zrae054
crossref_primary_10_1097_JN9_0000000000000047
crossref_primary_10_1016_j_ejrad_2023_111263
crossref_primary_10_21294_1814_4861_2024_23_4_77_85
Cites_doi 10.1080/14728222.2022.2036718
10.1186/s13045-020-00981-4
10.1007/s12032-010-9457-8
10.3748/wjg.v19.i34.5598
10.3748/wjg.v25.i31.4512
10.1038/bjc.2013.437
10.1245/s10434-011-2049-9
10.1093/annonc/mdn622
10.1016/S0140-6736(13)62224-2
10.3978/j.issn.2078-6891.2012.026
10.1016/j.canep.2016.02.001
10.1038/ajg.2017.155
10.1002/ijc.33285
10.1016/j.bbcan.2019.05.003
10.1159/000478863
10.3892/mco.2019.1843
10.1038/s41568-018-0024-5
10.1007/s00535-021-01815-x
10.1136/gutjnl-2014-308124
10.1053/j.gastro.2017.08.023
10.1053/j.gastro.2017.09.048
10.1016/S1470-2045(14)71123-4
10.1016/j.canep.2013.05.011
10.1016/S0140-6736(17)31462-9
10.1111/j.1442-2050.2006.00602.x
10.1007/s10552-014-0485-0
10.1093/jnci/djn211
10.4314/mmj.v27i3.3
10.1111/jgh.13289
10.1038/s41598-018-19819-8
10.1002/cncr.33119
10.3322/caac.21262
10.1016/j.dld.2018.08.002
10.1016/S2468-1253(20)30007-8
10.1002/ijc.30382
10.1056/NEJMoa1103042
10.1002/ijc.20616
10.1016/j.asjsur.2016.10.005
10.1002/ijc.20619
10.1007/s13277-014-2762-7
10.1186/s12957-020-02023-2
10.3978/j.issn.1000-9604.2015.01.06
10.1007/s12328-020-01237-x
10.1007/s10388-018-0641-9
10.1002/jso.25990
10.1371/journal.pone.0185778
10.1155/2019/1953497
ContentType Journal Article
Copyright 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
– notice: 2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1111/1759-7714.14745
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef



MEDLINE
Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals (ODIN)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Liu et al
EISSN 1759-7714
EndPage 11
ExternalDocumentID oai_doaj_org_article_a07c74af9a19464bb480c6f036332536
PMC9807450
36482832
10_1111_1759_7714_14745
TCA14745
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GeographicLocations Mongolia
Malawi
United States--US
Asia
Southern Africa
China
Africa
Zimbabwe
Central Asia
GeographicLocations_xml – name: Malawi
– name: Asia
– name: Zimbabwe
– name: Central Asia
– name: China
– name: Mongolia
– name: Africa
– name: United States--US
– name: Southern Africa
GrantInformation_xml – fundername: Wu Jieping Medical Foundation
  funderid: 320.6750.2022‐16‐16
– fundername: Capital Health Research and Development of Special Fund
  funderid: 2022‐2‐2024
– fundername: ;
  grantid: 320.6750.2022‐16‐16
– fundername: ;
  grantid: 2022‐2‐2024
GroupedDBID ---
05W
0R~
1OC
24P
31~
4.4
50Y
53G
5VS
7X7
8-0
8-1
8FI
8FJ
AAHHS
AANHP
AAWTL
AAZKR
ABDBF
ABUWG
ACBWZ
ACCFJ
ACCMX
ACRPL
ACUHS
ACXQS
ACYXJ
ADBBV
ADKYN
ADNMO
ADPDF
ADZMN
AEEZP
AENEX
AEQDE
AFBPY
AFKRA
AHMBA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
ASPBG
AVUZU
AVWKF
AZFZN
BCNDV
BDRZF
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
D-A
DIK
EBD
EBS
EJD
FEDTE
FYUFA
G-S
GODZA
GROUPED_DOAJ
HMCUK
HVGLF
HYE
HZ~
IAO
IHR
ITC
KQ8
MY.
MY~
O9-
OK1
OVD
PIMPY
PQQKQ
PROAC
RPM
RX1
SUPJJ
TEORI
UKHRP
WIN
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c5995-285271a15d91281efa4f93fd3067a1c7a6b8f716e39f9c23b45ce23bc2d675e13
IEDL.DBID 24P
ISSN 1759-7706
1759-7714
IngestDate Wed Aug 27 01:30:22 EDT 2025
Thu Aug 21 18:38:15 EDT 2025
Thu Jul 10 22:02:20 EDT 2025
Fri Jul 25 07:45:12 EDT 2025
Wed Feb 19 02:24:50 EST 2025
Thu Apr 24 22:52:43 EDT 2025
Tue Jul 01 00:59:11 EDT 2025
Wed Jan 22 16:19:50 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords mortality
esophageal cancer
projection
incidence
Language English
License Attribution-NonCommercial-NoDerivs
2022 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5995-285271a15d91281efa4f93fd3067a1c7a6b8f716e39f9c23b45ce23bc2d675e13
Notes Funding information
Capital Health Research and Development of Special Fund, Grant/Award Number: 2022‐2‐2024; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.2022‐16‐16
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
Funding information Capital Health Research and Development of Special Fund, Grant/Award Number: 2022‐2‐2024; Wu Jieping Medical Foundation, Grant/Award Number: 320.6750.2022‐16‐16
ORCID 0000-0002-7075-3732
0000-0001-6854-6040
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14745
PMID 36482832
PQID 2760009130
PQPubID 1006494
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_a07c74af9a19464bb480c6f036332536
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9807450
proquest_miscellaneous_2753310321
proquest_journals_2760009130
pubmed_primary_36482832
crossref_primary_10_1111_1759_7714_14745
crossref_citationtrail_10_1111_1759_7714_14745
wiley_primary_10_1111_1759_7714_14745_TCA14745
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2023
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: January 2023
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Singapore
– name: Tianjin
PublicationTitle Thoracic cancer
PublicationTitleAlternate Thorac Cancer
PublicationYear 2023
Publisher John Wiley & Sons Australia, Ltd
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: John Wiley & Sons, Inc
– name: Wiley
References 2017; 40
2015; 36
2019; 2019
2015; 16
2009; 20
2013; 109
2021; 148
2005; 113
2019; 10
2020; 126
2017; 390
2016; 31
2019; 16
2022; 26
2006; 19
2012; 19
2020; 13
2018; 41
2020; 122
2017; 112
2008; 100
2020; 18
2013; 19
2018; 18
2015; 26
2020; 5
2018; 154
2018; 8
2013; 37
2012; 3
2015; 27
2021; 56
2015; 64
2019; 25
2015; 65
2017; 12
2016; 41
2018
2016; 139
2018; 50
2011; 28
2014; 383
2019; 1872
2011; 365
e_1_2_8_28_1
e_1_2_8_29_1
Blot WJ (e_1_2_8_38_1) 2018
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 112
  start-page: 1247
  issue: 8
  year: 2017
  end-page: 55
  article-title: Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030
  publication-title: Am J Gastroenterol
– volume: 148
  start-page: 905
  issue: 4
  year: 2021
  end-page: 13
  article-title: Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
  publication-title: Int J Cancer
– volume: 3
  start-page: 226
  issue: 3
  year: 2012
  end-page: 31
  article-title: The association between obesity factor and esophageal caner
  publication-title: J Gastrointest Oncol
– volume: 13
  start-page: 1010
  issue: 6
  year: 2020
  end-page: 21
  article-title: Epidemiology of esophageal cancer: update in global trends, etiology and risk factors
  publication-title: Clin J Gastroenterol
– volume: 109
  start-page: 1367
  issue: 5
  year: 2013
  end-page: 72
  article-title: Poor oral hygiene and risk of esophageal squamous cell carcinoma in Kashmir
  publication-title: Br J Cancer
– volume: 113
  start-page: 456
  issue: 3
  year: 2005
  end-page: 63
  article-title: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China
  publication-title: Int J Cancer
– start-page: 579
  year: 2018
  end-page: 93
– volume: 18
  start-page: 549
  issue: 9
  year: 2018
  end-page: 61
  article-title: Deciphering the cells of origin of squamous cell carcinomas
  publication-title: Nat Rev Cancer
– volume: 18
  start-page: 252
  issue: 1
  year: 2020
  article-title: Long‐term outcomes and safety of radical transmediastinal esophagectomy with preoperative docetaxel, cisplatin, and 5‐fluorouracil combination chemotherapy for locally advanced squamous cell carcinoma of the thoracic esophagus
  publication-title: World J Surg Oncol
– volume: 19
  start-page: 5598
  issue: 34
  year: 2013
  end-page: 606
  article-title: Epidemiology of esophageal cancer
  publication-title: World J Gastroenterol
– volume: 27
  start-page: 2
  issue: 1
  year: 2015
  end-page: 12
  article-title: Annual report on status of cancer in China, 2011
  publication-title: Chin J Cancer Res
– volume: 16
  start-page: 1
  issue: 1
  year: 2019
  end-page: 24
  article-title: Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 1
  publication-title: Esophagus
– volume: 154
  start-page: 360
  issue: 2
  year: 2018
  end-page: 73
  article-title: Epidemiology of esophageal squamous cell carcinoma
  publication-title: Gastroenterology
– volume: 65
  start-page: 87
  issue: 2
  year: 2015
  end-page: 108
  article-title: Global cancer statistics, 2012
  publication-title: Ca‐Cancer J Clin
– volume: 126
  start-page: 4511
  issue: 20
  year: 2020
  end-page: 20
  article-title: Long‐term effectiveness of one‐time endoscopic screening for esophageal cancer: a community‐based study in rural China
  publication-title: Cancer
– volume: 50
  start-page: 991
  issue: 10
  year: 2018
  end-page: 6
  article-title: Prognostic factors in esophageal cancer treated with curative intent
  publication-title: Dig Liver Dis
– volume: 19
  start-page: 68
  issue: 1
  year: 2012
  end-page: 74
  article-title: A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5‐fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)
  publication-title: Ann Surg Oncol
– volume: 26
  start-page: 159
  issue: 1
  year: 2015
  end-page: 61
  article-title: Incidence trend of esophageal squamous cell carcinoma: an analysis of surveillance epidemiology, and end results (SEER) database
  publication-title: Cancer Causes Control
– volume: 25
  start-page: 4512
  issue: 31
  year: 2019
  end-page: 33
  article-title: Systematic review and meta‐analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes
  publication-title: World J Gastroenterol
– volume: 40
  start-page: 417
  issue: 7–8
  year: 2017
  end-page: 22
  article-title: Circulating tumor cells in esophageal cancer
  publication-title: Oncol Res Treat
– volume: 122
  start-page: 412
  issue: 3
  year: 2020
  end-page: 21
  article-title: Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?
  publication-title: J Surg Oncol
– volume: 365
  start-page: 1375
  issue: 15
  year: 2011
  end-page: 83
  article-title: Incidence of adenocarcinoma among patients with Barrett's esophagus
  publication-title: N Engl J Med
– volume: 16
  start-page: 36
  issue: 1
  year: 2015
  end-page: 46
  article-title: Global burden of cancer attributable to high body‐mass index in 2012: a population‐based study
  publication-title: Lancet Oncol
– volume: 390
  start-page: 2383
  issue: 10110
  year: 2017
  end-page: 96
  article-title: Oesophageal cancer
  publication-title: Lancet
– volume: 28
  start-page: 188
  issue: 1
  year: 2011
  end-page: 93
  article-title: Relevance of serum estradiol and estrogen receptor beta expression from a high‐incidence area for esophageal squamous cell carcinoma in China
  publication-title: Med Oncol
– volume: 56
  start-page: 891
  issue: 10
  year: 2021
  end-page: 902
  article-title: Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors
  publication-title: J Gastroenterol
– volume: 1872
  start-page: 37
  issue: 1
  year: 2019
  end-page: 48
  article-title: From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma
  publication-title: Biochim Biophys Acta Rev Cancer
– volume: 20
  start-page: 231
  issue: 2
  year: 2009
  end-page: 8
  article-title: Histological type of esophageal cancer might affect response to neo‐adjuvant radiochemotherapy and subsequent prognosis
  publication-title: Ann Oncol
– volume: 13
  start-page: 146
  issue: 1
  year: 2020
  article-title: Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up‐to‐date overview and comparison with those in Japan and South Korea
  publication-title: J Hematol Oncol
– volume: 36
  start-page: 1627
  issue: 3
  year: 2015
  end-page: 42
  article-title: p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India
  publication-title: Tumour Biol
– volume: 37
  start-page: 579
  issue: 5
  year: 2013
  end-page: 84
  article-title: Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption
  publication-title: Cancer Epidemiol
– volume: 12
  issue: 10
  year: 2017
  article-title: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: a nationwide population‐based cohort study of South Korea
  publication-title: PLoS One
– volume: 41
  start-page: 113
  year: 2016
  end-page: 21
  article-title: Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa
  publication-title: Cancer Epidemiol
– volume: 27
  start-page: 88
  issue: 3
  year: 2015
  end-page: 92
  article-title: Environmental risk factors for oesophageal cancer in Malawi: a case‐control study
  publication-title: Malawi Med J
– volume: 41
  start-page: 210
  issue: 3
  year: 2018
  end-page: 5
  article-title: Esophageal cancer: risk factors, genetic association, and treatment
  publication-title: Asian J Surg
– volume: 2019
  year: 2019
  article-title: Systematic review with meta‐analysis: association of infection with esophageal cancer
  publication-title: Gastroenterol Res Pract
– volume: 64
  start-page: 381
  issue: 3
  year: 2015
  end-page: 7
  article-title: Global incidence of oesophageal cancer by histological subtype in 2012
  publication-title: Gut
– volume: 8
  start-page: 4522
  issue: 1
  year: 2018
  article-title: Global incidence and mortality of oesophageal cancer and their correlation with socioeconomic indicators temporal patterns and trends in 41 countries
  publication-title: Sci Rep
– volume: 10
  start-page: 575
  issue: 6
  year: 2019
  end-page: 82
  article-title: Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment.
  publication-title: Clin Oncol
– volume: 5
  start-page: 582
  issue: 6
  year: 2020
  end-page: 97
  article-title: The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990‐2017: a systematic analysis for the global burden of disease study 2017
  publication-title: Lancet Gastroenterol Hepatol
– volume: 139
  start-page: 2436
  issue: 11
  year: 2016
  end-page: 46
  article-title: A global view on cancer incidence and national levels of the human development index
  publication-title: Int J Cancer
– volume: 154
  start-page: 437
  issue: 2
  year: 2018
  end-page: 51
  article-title: Management of patients with adenocarcinoma or squamous cancer of the esophagus
  publication-title: Gastroenterology
– volume: 31
  start-page: 1141
  issue: 6
  year: 2016
  end-page: 6
  article-title: Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis
  publication-title: J Gastroenterol Hepatol
– volume: 113
  start-page: 475
  issue: 3
  year: 2005
  end-page: 82
  article-title: Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan
  publication-title: Int J Cancer
– volume: 100
  start-page: 1184
  issue: 16
  year: 2008
  end-page: 7
  article-title: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age
  publication-title: J Natl Cancer Inst
– volume: 19
  start-page: 321
  issue: 5
  year: 2006
  end-page: 8
  article-title: Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma
  publication-title: Dis Esophagus
– volume: 383
  start-page: 549
  issue: 9916
  year: 2014
  end-page: 57
  article-title: Global cancer patterns: causes and prevention
  publication-title: Lancet
– volume: 26
  start-page: 107
  issue: 2
  year: 2022
  end-page: 17
  article-title: Esophageal cancer: emerging therapeutics
  publication-title: Expert Opin Ther Targets
– ident: e_1_2_8_8_1
  doi: 10.1080/14728222.2022.2036718
– ident: e_1_2_8_10_1
  doi: 10.1186/s13045-020-00981-4
– ident: e_1_2_8_23_1
  doi: 10.1007/s12032-010-9457-8
– ident: e_1_2_8_6_1
  doi: 10.3748/wjg.v19.i34.5598
– ident: e_1_2_8_4_1
  doi: 10.3748/wjg.v25.i31.4512
– ident: e_1_2_8_31_1
  doi: 10.1038/bjc.2013.437
– ident: e_1_2_8_45_1
  doi: 10.1245/s10434-011-2049-9
– ident: e_1_2_8_43_1
  doi: 10.1093/annonc/mdn622
– ident: e_1_2_8_48_1
  doi: 10.1016/S0140-6736(13)62224-2
– ident: e_1_2_8_25_1
  doi: 10.3978/j.issn.2078-6891.2012.026
– ident: e_1_2_8_26_1
  doi: 10.1016/j.canep.2016.02.001
– ident: e_1_2_8_14_1
  doi: 10.1038/ajg.2017.155
– ident: e_1_2_8_24_1
  doi: 10.1002/ijc.33285
– ident: e_1_2_8_13_1
  doi: 10.1016/j.bbcan.2019.05.003
– ident: e_1_2_8_20_1
  doi: 10.1159/000478863
– ident: e_1_2_8_47_1
  doi: 10.3892/mco.2019.1843
– ident: e_1_2_8_9_1
  doi: 10.1038/s41568-018-0024-5
– ident: e_1_2_8_39_1
  doi: 10.1007/s00535-021-01815-x
– ident: e_1_2_8_7_1
  doi: 10.1136/gutjnl-2014-308124
– ident: e_1_2_8_12_1
  doi: 10.1053/j.gastro.2017.08.023
– ident: e_1_2_8_18_1
  doi: 10.1053/j.gastro.2017.09.048
– ident: e_1_2_8_36_1
  doi: 10.1016/S1470-2045(14)71123-4
– ident: e_1_2_8_32_1
  doi: 10.1016/j.canep.2013.05.011
– ident: e_1_2_8_2_1
  doi: 10.1016/S0140-6736(17)31462-9
– ident: e_1_2_8_17_1
  doi: 10.1111/j.1442-2050.2006.00602.x
– ident: e_1_2_8_40_1
  doi: 10.1007/s10552-014-0485-0
– ident: e_1_2_8_41_1
  doi: 10.1093/jnci/djn211
– ident: e_1_2_8_29_1
  doi: 10.4314/mmj.v27i3.3
– ident: e_1_2_8_19_1
  doi: 10.1111/jgh.13289
– ident: e_1_2_8_16_1
  doi: 10.1038/s41598-018-19819-8
– ident: e_1_2_8_49_1
  doi: 10.1002/cncr.33119
– ident: e_1_2_8_11_1
  doi: 10.3322/caac.21262
– ident: e_1_2_8_44_1
  doi: 10.1016/j.dld.2018.08.002
– ident: e_1_2_8_3_1
  doi: 10.1016/S2468-1253(20)30007-8
– ident: e_1_2_8_15_1
  doi: 10.1002/ijc.30382
– ident: e_1_2_8_35_1
  doi: 10.1056/NEJMoa1103042
– start-page: 579
  volume-title: Cancer Epidemiology and Prevention
  year: 2018
  ident: e_1_2_8_38_1
– ident: e_1_2_8_30_1
  doi: 10.1002/ijc.20616
– ident: e_1_2_8_21_1
  doi: 10.1016/j.asjsur.2016.10.005
– ident: e_1_2_8_34_1
  doi: 10.1002/ijc.20619
– ident: e_1_2_8_33_1
  doi: 10.1007/s13277-014-2762-7
– ident: e_1_2_8_46_1
  doi: 10.1186/s12957-020-02023-2
– ident: e_1_2_8_27_1
  doi: 10.3978/j.issn.1000-9604.2015.01.06
– ident: e_1_2_8_5_1
  doi: 10.1007/s12328-020-01237-x
– ident: e_1_2_8_28_1
  doi: 10.1007/s10388-018-0641-9
– ident: e_1_2_8_42_1
  doi: 10.1002/jso.25990
– ident: e_1_2_8_22_1
  doi: 10.1371/journal.pone.0185778
– ident: e_1_2_8_37_1
  doi: 10.1155/2019/1953497
SSID ssj0000389025
Score 2.620096
SecondaryResourceType review_article
Snippet Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths from...
Abstract Esophageal cancer is a familiar malignancy with high incidence and mortality, and the overall prognosis is poor. The numbers of cases of and deaths...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 3
SubjectTerms African Americans
Age
Epidemiology
Esophageal cancer
Esophageal Neoplasms - epidemiology
Human Development Index
Humans
Incidence
Mortality
Population
Prognosis
projection
Regions
Review
Risk Factors
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NSx0xEB-Kh9KLaGvrVltS8NDL6m6S_cjRio-HYE8K3kI-UZB9os9D_3tnsnnP97DixdMuSZYNk0nmN5nkNwAH3lq0SojcXBdkKb3ipUHDXHpneGUdOiGRLief_22nl_LsqrlaSfVFZ8JGeuBRcEem6lwnTVQG3e1WWiv7yrWR4o-CNyKRbaPNW3Gm0hosUvws3YZsFELIqs28PnSMJ5fVEteJji4yrZikxNz_P7j58tTkKppN5miyBZsZR7Ljsf_b8CEMn-HjeY6Uf4Gz0-fUr__YLLJA-Qpw8cCPHI30PbsZGEcYx8zgWd6QIR1k8xmWi7Gc4-zbgcvJ6cXJtMx5E0pH9GEl7xve1aZuvKI4WYhGRiWiJ-_A1K4zre0j-klBqKgcF1Y2LuDDcY_uQ6jFV9gYZkPYBeY7i4hPeS-VlV4a27eV8dI6oayTLhRwuBCddplUnHJb3OqFc0Gy1iRrnWRdwO_lB3cjn8brTf_QWCybERF2KkD10Fk99FvqUcD-YiR1np0PmlM0kghRqwJ-LatxXlGwxAxh9khtEAgT22BdwLdx4Jc9Ea3sKcVTAd2aSqx1db1muLlO3N2KyIca_O9hUp63ZKAvTo7Ty_f3EMYefEK9EuMO0j5szO8fww_EVHP7M02fJ4fME70
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Ja90wEB7aFEovId3dpEWFHnpxakuyZZ1KGhJCID0l8G5Cm9tAsdOXl0P-fWdkPSePbicbWcb2LJpN_gbgQ3AOrRJ6bl5FWcqgeWnRMJfBW145j0FITz8nn31tTy7k6aJZ5ITbdd5WuV4T00IdRk858k-cKkgEYll9vvpZUtcoqq7mFhoP4RFBl9GWLrVQc46FwOOq1HcVjaRGR7JqM7oPbebJY7XE1ULR70z3DFPC7_-T0_n73sn7Pm0ySsc7sJ29SXYwsf8pPIjDM3h8luvlz-H06K4B7C0bexapawEuIXiTJ34v2eXAODpzzA6B5bQMSSJbjTgupnGOOvgCLo6Pzg9Pytw9ofQEIlbyruGqtnUTNFXLYm9lr0UfKEawtVe2dV2P0VIUuteeCycbH_HgecAgItbiJWwN4xBfAwvKod-nQ5DaySCt69rKBum80M5LHwvYX5PO-AwtTh0ufph1iEG0NkRrk2hdwMf5hqsJVePvU78QL-ZpBIedBsblN5O1y9hKeSVtr22tZSudk13l256K1II3oi1gb81Jk3X02txJVAHv58uoXVQysUMcb2gOusOEOVgX8Gpi_PwmopUdNXoqQG2IxMarbl4ZLr8nBG9NEEQNPnc_Cc__aGDODw_SyZt_f8cuPEGJEVOGaA-2Vsub-BZ9ppV7lxTjF4EpDDY
  priority: 102
  providerName: ProQuest
Title Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2F1759-7714.14745
https://www.ncbi.nlm.nih.gov/pubmed/36482832
https://www.proquest.com/docview/2760009130
https://www.proquest.com/docview/2753310321
https://pubmed.ncbi.nlm.nih.gov/PMC9807450
https://doaj.org/article/a07c74af9a19464bb480c6f036332536
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aBEovpe-6TRcVeujFxZZkyzomYUMIJISSQG5GzzZQ7LLZHPrvOyNr3WwflF5sI0u2Gc14XtI3AO-9taiV0HJzKshSes1Lg4q59M7wyjp0QiJtTj49a48v5clVs1lNSHthJnyIOeBGkpH-1yTgxt7cEXLUexptw1qisCvZ3Idd2mBL8Plcns9hFsKPq1Lp1dy_ajPAD63n-eUZW7opQfj_ye78ffnkXbM26aWjx_AoG5Rsf-KAJ3AvDE_hwWlOmT-Dk-XPGrDf2RhZoMIF-BfBQY6mfMWuB8bRnmNm8CxHZogZ2XrEdjG1cxTD53B5tLw4PC5zAYXSEY5YybuGq9rUjdeUMAvRyKhF9OQmmNop09ouosMUhI7acWFl4wKeHPfoR4RavICdYRzCK2BeWTT9tPdSW-mlsV1bGS-tE9o66UIBHzek611GF6ciF1_7jZdBtO6J1n2idQEf5gHfJmCNv3c9oLmYuxEidmoYV5_7LGC9qZRT0kRtao1sYK3sKtdGylML3oi2gL3NTPZZTG96TmlJQkatCng330YBo6yJGcJ4S33QIibYwbqAl9PEz18iWtlRracC1BZLbH3q9p3h-ksC8daEQtTgeycm_xcN-ovD_XTx-n8HvIGHyENiChvtwc56dRveoiG1toskKnhUV2oBuwfLs_NPixSU-AHiFxE_
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVIJeEG8MBYwEEhcXe3f92ANCbUmVPhIhlEq9ufsyrYTskqZC_VP8RmbsddqI16mnROt17MzO7Hyzs_sNwBurNXolRG4mdyISVrJIoWOOrFEs1gaDkIoOJ48n2ehQ7B2lRyvwsz8LQ9sq-zmxnahtY2iN_D2jDBKRWMYfz75HVDWKsqt9CY1OLfbd5Q8M2c4_7H7C8X3L2M5wuj2KfFWByBC5VsSKlOWJSlIrKYvkKiUqyStL2FklJleZLiqMIhyXlTSMa5Eahx-GWQTXLuH4u7dgVXAMZQawujWcfP6yWNUhurq4rfSKblkidI0zzydE24d8WyJwfsrpANU1V9hWDPgTzP19t-Z1FN26wZ17cNfj13CzU7j7sOLqB3B77DP0D2FveFVy9jJsqtBRnQSctPAmQxo2C0_rkCF8DFVtQ78QRLofzhts5107Q6t_BIc3ItnHMKib2j2F0OYakaa0VkgtrFC6yGJlhTZcaiOMC2CjF11pPJk51dT4VvZBDcm6JFmXrawDeLe44azj8fh71y0ai0U3IuBuG5rZ19Lbc6ni3ORCVVIlUmRCa1HEJqsoLc5ZyrMA1vuRLP2scF5e6XAArxeX0Z4pSaNq11xQHwTgxHKYBPCkG_jFm_BMFFRaKoB8SSWWXnX5Sn160nKGSyI9SvG5G63y_E8G5XR7s_3y7N__4xXcGU3HB-XB7mT_Oayh9vBufWodBvPZhXuBiG2uX3ozCeH4pi3zF3OxSXs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEO8GCgQJJC5pE9uJ4wNCpe2qD1pxaKW9Bb8ClVBStluh_jV-HTOJk3bF69TTrhxnkx3P47PH_gbgtTMGoxIiNyu9SIRTLNEYmBNnNUuNxUlITYeTD4-K3ROxP82nS_BzOAtD2yoHn9g5atdaWiPfYJRBIhLLdKMO2yI-bU_en31PqIIUZVqHchq9ihz4yx84fTt_t7eNY_2GscnO8dZuEioMJJaIthJW5kxmOsudooySr7WoFa8d4WidWakLU9Y4o_Bc1coybkRuPX5Y5hBo-4zj796C25LnGdmYnMpxfYeI69Ku5isGaIUgNi0CsxBtJAptmUBPJeko1bWg2NUO-BPg_X3f5nU83QXEyT24G5BsvNmr3n1Y8s0DWDkMufqHsL9zVXz2Mm7r2FPFBHRfeJMlXZvFp03MEEjGunFxWBIiK4jnLbbzvp2h_T-CkxuR62NYbtrGr0LspEHMqZwTyggntCmLVDthLFfGCusjWB9EV9lAa07VNb5Vw_SGZF2RrKtO1hG8HW846xk9_t71A43F2I2ouLuGdvalCpZd6VRaKXStdKZEIYwRZWqLmhLknOW8iGBtGMkq-Ifz6kqbI3g1XkbLpnSNbnx7QX0QihPfYRbBk37gxzfhhSipyFQEckElFl518Upz-rVjD1dEf5Tjc9c75fmfDKrjrc3uy9N__4-XsIL2WH3cOzp4BndQeXi_ULUGy_PZhX-O0G1uXnQ2EsPnmzbKX5lRTEs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+esophageal+cancer+in+2020+and+projections+to+2030+and+2040&rft.jtitle=Thoracic+cancer&rft.au=Liu%2C+Chun%E2%80%90Quan&rft.au=Ma%2C+Yun%E2%80%90Lei&rft.au=Qin%2C+Qi&rft.au=Wang%2C+Pei%E2%80%90Hao&rft.date=2023-01-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1759-7706&rft.eissn=1759-7714&rft.volume=14&rft.issue=1&rft.spage=3&rft.epage=11&rft_id=info:doi/10.1111%2F1759-7714.14745&rft.externalDBID=10.1111%252F1759-7714.14745&rft.externalDocID=TCA14745
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-7706&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-7706&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-7706&client=summon